DE69019431T2 - Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions. - Google Patents
Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.Info
- Publication number
- DE69019431T2 DE69019431T2 DE69019431T DE69019431T DE69019431T2 DE 69019431 T2 DE69019431 T2 DE 69019431T2 DE 69019431 T DE69019431 T DE 69019431T DE 69019431 T DE69019431 T DE 69019431T DE 69019431 T2 DE69019431 T2 DE 69019431T2
- Authority
- DE
- Germany
- Prior art keywords
- medicament
- manufacture
- keto
- excretion
- potassium ion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229910001414 potassium ion Inorganic materials 0.000 title abstract 2
- RDMCNIUUUCHPTN-ZWKOTPCHSA-N 7-[(1s,2r)-2-(3-oxooctyl)cyclopentyl]heptanoic acid Chemical class CCCCCC(=O)CC[C@H]1CCC[C@@H]1CCCCCCC(O)=O RDMCNIUUUCHPTN-ZWKOTPCHSA-N 0.000 title 1
- 230000029142 excretion Effects 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- WGJJROVFWIXTPA-OALUTQOASA-N prostanoic acid Chemical class CCCCCCCC[C@H]1CCC[C@@H]1CCCCCCC(O)=O WGJJROVFWIXTPA-OALUTQOASA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19709089 | 1989-07-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69019431D1 DE69019431D1 (de) | 1995-06-22 |
DE69019431T2 true DE69019431T2 (de) | 1995-09-14 |
Family
ID=16368563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69019431T Expired - Lifetime DE69019431T2 (de) | 1989-07-27 | 1990-07-20 | Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions. |
Country Status (6)
Country | Link |
---|---|
US (2) | US5075334A (de) |
EP (1) | EP0410652B1 (de) |
JP (1) | JP2609479B2 (de) |
AT (1) | ATE122563T1 (de) |
CA (1) | CA2022323C (de) |
DE (1) | DE69019431T2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002062356A2 (en) * | 2001-02-06 | 2002-08-15 | Ash Medical Systems, Inc. | Monovalent-selective cation exchangers as oral sorbent therapy |
US20020133009A1 (en) * | 2001-03-13 | 2002-09-19 | Lambrou George N. | Method for opening potassium channels |
US20080234337A1 (en) * | 2004-08-10 | 2008-09-25 | Ono Pharmaceutical Co., Ltd. | Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6027669B2 (ja) * | 1976-12-30 | 1985-06-29 | ジ・アツプジヨン・カンパニ− | プロスタグランジン類似体 |
DE3115997A1 (de) * | 1981-04-13 | 1982-11-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | "neue prostaglandine und prostacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel" |
DE3121155A1 (de) * | 1981-05-22 | 1982-12-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3221193A1 (de) * | 1982-05-28 | 1983-12-01 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue carbacyclinester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3322893A1 (de) * | 1983-06-23 | 1985-01-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue prostacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
DE3608088C2 (de) * | 1986-03-07 | 1995-11-16 | Schering Ag | Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
EP0292177B1 (de) * | 1987-05-15 | 1992-03-25 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Fiebersteigende Zusammensetzung |
DE3725031A1 (de) * | 1987-07-24 | 1989-02-02 | Schering Ag | Neue 9-substituierte carbacyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
ES2052735T3 (es) * | 1987-09-18 | 1994-07-16 | R Tech Ueno Ltd | Un metodo para producir un agente hipotensor ocular. |
ES2051862T3 (es) * | 1987-10-02 | 1994-07-01 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para producir un medicamento que tiene un efecto catartico. |
JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化 |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
ES2055051T3 (es) * | 1988-05-23 | 1994-08-16 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea. |
-
1990
- 1990-07-20 DE DE69019431T patent/DE69019431T2/de not_active Expired - Lifetime
- 1990-07-20 AT AT90307944T patent/ATE122563T1/de not_active IP Right Cessation
- 1990-07-20 EP EP90307944A patent/EP0410652B1/de not_active Expired - Lifetime
- 1990-07-24 JP JP2196743A patent/JP2609479B2/ja not_active Expired - Fee Related
- 1990-07-25 CA CA002022323A patent/CA2022323C/en not_active Expired - Lifetime
- 1990-07-26 US US07/557,834 patent/US5075334A/en not_active Ceased
-
1992
- 1992-09-30 US US07/953,786 patent/USRE34756E/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5075334A (en) | 1991-12-24 |
DE69019431D1 (de) | 1995-06-22 |
JPH03130227A (ja) | 1991-06-04 |
CA2022323C (en) | 1995-07-25 |
JP2609479B2 (ja) | 1997-05-14 |
ATE122563T1 (de) | 1995-06-15 |
EP0410652A2 (de) | 1991-01-30 |
USRE34756E (en) | 1994-10-11 |
CA2022323A1 (en) | 1991-01-28 |
EP0410652B1 (de) | 1995-05-17 |
EP0410652A3 (en) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033040T2 (de) | Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF) | |
DE3784693D1 (de) | Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen. | |
FI906438A0 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi | |
FI905003A (fi) | Glykosaminoglykan modifierat protein. | |
ATE135577T1 (de) | Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht | |
DE69224124T2 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
ATE14597T1 (de) | Verfahren zur enzymatischen herstellung von l-2- amino-4-methylphosphinobuttersaeure. | |
DE68904462T2 (de) | 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten. | |
IE882529L (en) | Platinum Coordination Compound | |
ATE71078T1 (de) | Glyzerinderivate. | |
DE69019431D1 (de) | Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions. | |
ATE113939T1 (de) | Verfahren zur herstellung von cephalosporin und zwischenverbindungen. | |
ATE78395T1 (de) | Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht. | |
ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
ATE92056T1 (de) | Verfahren zur herstellung von 5-chlor-3chlorsulfonyl-2-thiophencarbonsaeureestern. | |
IT1136588B (it) | Procedimento per produrre l-amminoacido ossidasi | |
ATE135702T1 (de) | Aryl- oder heteroaryl-1-alkyl-pyrrol-2- carbonsäure-derivate, zur behandlung von durch interleukin-1 hervorgerufenen erkrankungen | |
ATE93832T1 (de) | Verfahren zur herstellung von 4,6-dimethyl-7hydroxynonan-3-on. | |
ATE18410T1 (de) | Kristallines human-leukocyten-interferon. | |
DE69018903D1 (de) | Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme. | |
ATE6933T1 (de) | Verfahren zur herstellung von 4aminobutters[ureamid. | |
ATE4202T1 (de) | Verfahren zur herstellung von pyrrol-2essigs[ureestern. | |
DE3578065D1 (de) | 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate, verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten. | |
ATE58476T1 (de) | Verwendung von doxaminol zur herstellung eines arzneimittels zur behandlung der peripheren arteriellen verschlusskrankheit. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SUCAMPO AG, ZUG, CH |